| Literature DB >> 23171550 |
Aaron Z Welch1, Patrick A Gibney, David Botstein, Douglas E Koshland.
Abstract
Tolerance to desiccation in cultures of Saccharomyces cerevisiae is inducible; only one in a million cells from an exponential culture survive desiccation compared with one in five cells in stationary phase. Here we exploit the desiccation sensitivity of exponentially dividing cells to understand the stresses imposed by desiccation and their stress response pathways. We found that induction of desiccation tolerance is cell autonomous and that there is an inverse correlation between desiccation tolerance and growth rate in glucose-, ammonia-, or phosphate-limited continuous cultures. A transient heat shock induces a 5000-fold increase in desiccation tolerance, whereas hyper-ionic, -reductive, -oxidative, or -osmotic stress induced much less. Furthermore, we provide evidence that the Sch9p-regulated branch of the TOR and Ras-cAMP pathway inhibits desiccation tolerance by inhibiting the stress response transcription factors Gis1p, Msn2p, and Msn4p and by activating Sfp1p, a ribosome biogenesis transcription factor. Among 41 mutants defective in ribosome biogenesis, a subset defective in 60S showed a dramatic increase in desiccation tolerance independent of growth rate. We suggest that reduction of a specific intermediate in 60S biogenesis, resulting from conditions such as heat shock and nutrient deprivation, increases desiccation tolerance.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23171550 PMCID: PMC3541959 DOI: 10.1091/mbc.E12-07-0524
Source DB: PubMed Journal: Mol Biol Cell ISSN: 1059-1524 Impact factor: 4.138
FIGURE 1:Desiccation tolerance is acquired in a cell-autonomous manner. Exponential-phase G418R cells (gal3Δ) were resuspended in four conditions: medium from saturated cells, medium and cells from stationary-phase culture, cells from stationary-phase culture in dilute PBS, or in dilute PBS alone. These were then assayed for desiccation tolerance at the indicated times. Controls (left) are G418R cells (gal3Δ) in either exponential or stationary phase.
FIGURE 2:Starvation can induce desiccation tolerance. (A) Exponential-phase BY4742 cells were transferred from rich medium containing glucose to the same medium without glucose, and samples were taken at the indicated times and assayed for desiccation tolerance. (B) Strain DBY12000 was grown under defined media conditions in a chemostat at constant doubling time at the times and nutrient-limiting conditions indicated until steady-state conditions were reached, and then were tested for desiccation tolerance using the described protocol (see Materials and Methods). The experiment was performed in triplicate, and representative results are shown.
FIGURE 3:Pretreatment with heat, but not other stresses, highly induces desiccation tolerance. (A) Exponential-phase BY4742 cells growing at 30°C in rich medium were pelleted and resuspended in the same medium with or without 1 M sodium chloride or 1.5 M sorbitol added or preheated to 39°C in rich medium at an OD600 < 0.6 and desiccated at the indicated time points and then assessed for viability. (B) Cells from the same experiment indicated in (A) were also treated for thermotolerance at the same time points by incubating at 52°C for 15 min and then assessed for viability. (C) Exponential-phase BY4742 cells from rich medium were collected and resuspended in rich medium with or without dithiothreitol or H2O2 added, and samples were assayed for desiccation tolerance at the indicated time points. (D) Growth rates of indicated cultures. Growth rate was calculated using the following formula: ΔTime/(Log2[Cell densityfinal/Cell densityinital]). The time period used to assess growth rate for each culture was between 1 and 3 h.
FIGURE 4:The TOR pathway inhibits desiccation tolerance in exponential-phase cells. (A) Exponential-phase cells growing in rich medium were transferred to the same media containing either rapamycin or the vehicle (ethanol) and then assayed for desiccation tolerance or heat tolerance after 6–10 h incubation while diluting to maintain OD600 < 0.6. (B) Exponential-phase cells growing in rich medium were transferred to the same media with either rapamycin or the vehicle (ethanol) added and then assayed for desiccation tolerance at the indicated time points, while maintaining OD600 < 0.6. (C) Cells containing a rapamycin-insensitive allele of TOR1 (tor1-1) and wild-type cells were assayed for desiccation tolerance as described in (A). (D) Exponential-phase cells of the indicated genotype were assayed for desiccation tolerance as described in (A).
FIGURE 5:Effectors of Tap42 branch do not significantly affect desiccation tolerance. (A) Genetic pathways model depicting TORC1’s downstream effectors. (B) Cells of the indicated genotype were grown to exponential phase in rich medium at 23°C and either assayed for desiccation tolerance or transferred to the same medium at 30°C for 6 h, then assayed for desiccation tolerance. (C) Exponential-phase cells of the indicated genotype were assayed for desiccation tolerance as described in Figure 4A.
FIGURE 6:The Sch9 branch of the TOR pathway inhibits desiccation tolerance. (A) Genetic pathways model depicting TORC1’s downstream effectors. (B) Exponential-phase cultures of the indicated genotypes grown in rich medium were assayed for desiccation tolerance. (C) Exponential-phase cells of the indicated genotype were assayed for desiccation tolerance as described in Figure 4A.
FIGURE 7:The Ras-cAMP pathway modulates desiccation tolerance. (A) Model depicting Ras-cAMP regulation of desiccation tolerance. (B) Exponential-phase cultures of the indicated genotype grown in rich medium were assayed for desiccation tolerance. (C) Exponential-phase ras2Δ cells carrying either a vector expressing a dominant-negative allele of RAS2 or an empty vector were grown in SC medium lacking leucine and methionine for 24 h then assayed for desiccation tolerance. (D) Exponential-phase cells carrying a vector expressing PDE2, MSI1, or an empty-vector control were grown in yeast extract peptone (YEP) with 2% galactose for 24 h then assayed for desiccation tolerance. Exponential-phase cells carrying a vector expressing BCY1 or an empty-vector control were grown in SC medium lacking histidine and assayed for desiccation tolerance. (E) Cells with either cyr1 allele or the wild-type allele of CYR1 were grown to exponential phase at 23°C and then assayed for desiccation tolerance or transferred to the same medium at 30°C for 6 h and then assayed for desiccation tolerance.
FIGURE 8:Common effectors of PKA and Sch9p affect desiccation tolerance. (A) Genetic pathways model depicting PKA and Sch9p's downstream effectors. (B) Exponential-phase cells grown in rich medium with rapamycin of the indicated genotype were assayed for desiccation tolerance as described in Figure 4A. (C) Exponential-phase cells carrying a vector expressing MSN2, MSN4, GIS1, or an empty-vector control were grown in YEP with 2% galactose for 20 h and then assayed for desiccation tolerance. (D) Exponential-phase cultures of the indicated genotype grown in rich medium were assayed for desiccation tolerance.
FIGURE 9:Decreases in ribosome biogenesis can increase desiccation tolerance. (A) Wild-type cells grown in rich medium were transferred to the same medium containing the indicated concentrations of cycloheximide (CHX) and were assayed for desiccation tolerance at the indicated time points. (B) Strains containing a temperature-sensitive allele of a ribosome biogenesis gene or the wild-type strain were grown in rich medium to exponential phase at 23°C, shifted to 33°C for 6 h, then assayed for desiccation tolerance and growth rate. Presented here is only the desiccation tolerance. (C) Here the same data for desiccation tolerance are shown as in (B), but they are now plotted against the doubling time. The wild-type strain has a striped box, whereas all mutant strains have a solid black box. A logarithmic-regression line was fitted to these data. The equation for this line is y = 0.0093e–0.337x, and the R2 value of this line is displayed.
Yeast strains used in this study.
| Name | Genotype | Source |
|---|---|---|
| AW6400 | This study | |
| DBY12000 | MAT |
|
| BY4742 | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 | American Type Culture Collection (ATCC) |
| AW6410 | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 URA3 | This study |
| AW6413 | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 sch9::LEU2 | This study |
| AW6421 | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 URA3 PGAL1-MSI1 | This study |
| AW6423 | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 HIS3 | This study |
| AW6430 | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 URA3 PGAL1-MSN2 | This study |
| AW6431 | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 URA3 PGAL1-MSN4 | This study |
| AW6433 | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 ras2::G418R PMET3-Empty LEU2 | This study |
| AW6434 | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 ras2::G418R PMET3-RAS2a22 LEU2 | This study |
| AW6473 | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 msn2:: NATR msn4:: HYGR | This study |
| AW6481 | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 PGAL1-PDE2 URA3 | This study |
| AW6500 | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 rtg3:: NATR | This study |
| AW6507 | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 sfp1:: NATR | This study |
| AW6510 | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 gln3::NATR | This study |
| AW6514 | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 gln3::NATR ure2::G418R | This study |
| AW6517 | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 sch9::HYGR | This study |
| AW6518 | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 atg17::HYGR | This study |
| AW6531 | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 PGPD-BCY1 URA3 | This study |
| AW6532 | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 PGPD-BCY1 HIS3 | This study |
| AW6540 | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 msn2:: NATR msn4:: HYGR gis1:: G418R | This study |
| atg1Δ | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 atg1::G418R | ATCC |
| atg13Δ | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 atg13::G418R | ATCC |
| gal3Δ | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 gal3::G418R | ATCC |
| gat1Δ | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 gat1::G418R | ATCC |
| gis1Δ | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 gis1::G418R | ATCC |
| rim15Δ | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 rim15::G418R | ATCC |
| rtg3Δ | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 rtg3::G418R | ATCC |
| sfp1Δ | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 sfp1::G418R | ATCC |
| tor1Δ | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 tor1::URA3 | This study |
| tor1-1 | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 tor1-1 | This study |
| ure2Δ | MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 ure2::G418R | ATCC |
| cyr1ts | MATα his3∆1 leu2∆0 met15∆0 ura3∆0 G418R cyr1-ts |
Plasmids used in this study.
| Name | Marker | Description | Promoter | Copy number | Source |
|---|---|---|---|---|---|
| pPHY2701 | LEU2 | PMET3-Ras2a22 | Met3 | Centromeric |
|
| pAW14 | LEU2 | PMET3-Empty | Met3 | Centromeric | This study |
| pAW15 | URA3 | PGAL1-MSN2 | Gal1-10 | Centromeric | This study |
| pAW16 | URA3 | PGAL1-MSN4 | Gal1-10 | Centromeric | This study |
| pGal-GIS1 | URA3 | PGAL1-GIS1 | Gal1-10 | Centromeric | Harvard Institute of Proteomics FLEXGene Collection |
| pBY011 | URA3 | PGAL1-Empty | Gal1-10 | Centromeric | Harvard Institute of Proteomics FLEXGene Collection |
| pGal-MSI1 | URA3 | PGAL1-MSI1 | Gal1-10 | Centromeric | Harvard Institute of Proteomics FLEXGene Collection |
| pGal-PDE2 | URA3 | PGAL1-PDE2 | Gal1-10 | Centromeric | Harvard Institute of Proteomics FLEXGene Collection |
| pRS303 | HIS3 | HIS3 | None | Integrating | LabLife™ |
| HTP21 | HIS3 | PGPD-BCY1 | GAPDH | Centromeric |
|
| HTP22 | HIS3 | PGPD-BCY1 | GAPDH | Centromeric |
|
Composition of synthetic medium used in continuous cultures.
| Glucose-limited medium | Phosphate-limited medium | Nitrogen-limited medium |
|---|---|---|
| 1X vitamins* | 1X vitamins* | 1X vitamins* |
| 1X metals** | 1X metals** | 1X metals** |
| 20.0 g/l glucose (111 mM) | 20.0 g/l glucose (111 mM) | |
| 1.0 g/l CaCl2 (6.8 mM) | 1.0 g/l CaCl2 (6.8 mM) | 1.0 g/l CaCl2 (6.8 mM) |
| 1.0 g/l NaCl (17.1 mM) | 1.0 g/l NaCl (17.1 mM) | 1.0 g/l NaCl (17.1 mM) |
| 5.0 g/l MgSO4 (20.3 mM) | 5.0 g/l MgSO4 (20.3 mM) | 5.0 g/l MgSO4 (20.3 mM) |
| 50.0 g/l (NH4)2SO4 (378.4 mM) | 50.0 g/l (NH4)2SO4 (378.4 mM) | 10.0 g/l KH2PO4 (73.5 mM) |
| 10.0 g/l KH2PO4 (73.5 mM) | 1.0 g/l KCl (13.4 mM) | |
The limiting nutrient is shown in bold. See Table 4 for asterisk descriptions.
Composition of vitamins or metals used in continuous cultures.
| 8.19 nM biotin | 8.09 μM boric acid |
| 0.86 μM calcium panthothenate | 0.16 μM copper sulfate |
| 4.53 nM folic acid | 0.60 μM potassium iodide |
| 11.1 μM inositol (myo-inositol) | 0.74 μM ferric chloride |
| 3.25 μM niacin (nicotinic acid) | 2.37 μM manganese chloride |
| 1.46 μM | 0.83 μM sodium molybdate |
| 1.95 μM pyridoxine HCl | 1.39 μM zinc sulfate |
| 0.53 μM riboflavin | |
| 1.19 μM thiamine HCl |